Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 65

1.
2.

Mortality associated with statins in men with advanced prostate cancer treated with androgen deprivation therapy.

Wu SY, Fang SC, Shih HJ, Wen YC, Shao YJ.

Eur J Cancer. 2019 May;112:109-117. doi: 10.1016/j.ejca.2018.11.032. Epub 2019 Feb 28.

PMID:
30827745
3.

Fractionated ionizing radiation facilitates interferon-γ signaling and anticancer activity in lung adenocarcinoma cells.

Wu SY, Chen CL, Tseng PC, Chiu CY, Lin YE, Lin CF.

J Cell Physiol. 2019 Feb 14. doi: 10.1002/jcp.28258. [Epub ahead of print]

PMID:
30767202
4.

Effects of duodenal-jejunal bypass surgery in ameliorating nonalcoholic steatohepatitis in diet-induced obese rats.

Yu HH, Hsieh MC, Wu SY, Sy ED, Shan YS.

Diabetes Metab Syndr Obes. 2019 Jan 17;12:149-159. doi: 10.2147/DMSO.S190631. eCollection 2019.

5.

Risk of cardiotoxicity induced by adjuvant anthracycline-based chemotherapy and radiotherapy in young and old Asian women with breast cancer.

Lee CH, Zhang JF, Yuan KS, Wu ATH, Wu SY.

Strahlenther Onkol. 2019 Jan 28. doi: 10.1007/s00066-019-01428-7. [Epub ahead of print]

PMID:
30690687
6.

Experience of applying cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for ovarian teratoma with malignant transformation and peritoneal dissemination.

Yu HH, Yonemura Y, Hsieh MC, Lu CY, Wu SY, Shan YS.

Ther Clin Risk Manag. 2019 Jan 14;15:129-136. doi: 10.2147/TCRM.S190641. eCollection 2019.

7.

Letter: association between proton pump inhibitors and the risk of hepatocellular carcinoma-authors' reply.

Shao YJ, Wu SY.

Aliment Pharmacol Ther. 2018 Nov;48(10):1165-1166. doi: 10.1111/apt.15014. No abstract available.

PMID:
30375685
8.

Predicting 90-Day Mortality in Locoregionally Advanced Head and Neck Squamous Cell Carcinoma after Curative Surgery.

Qin L, Chen TM, Kao YW, Lin KC, Yuan KS, Wu ATH, Shia BC, Wu SY.

Cancers (Basel). 2018 Oct 22;10(10). pii: E392. doi: 10.3390/cancers10100392.

9.

Comorbidity profiles among patients with recurrent aphthous stomatitis: A case-control study.

Lin KC, Tsai LL, Ko EC, Sheng-Po Yuan K, Wu SY.

J Formos Med Assoc. 2019 Mar;118(3):664-670. doi: 10.1016/j.jfma.2018.10.002. Epub 2018 Oct 19.

10.

Fucoidan Inhibits Radiation-Induced Pneumonitis and Lung Fibrosis by Reducing Inflammatory Cytokine Expression in Lung Tissues.

Yu HH, Chengchuan Ko E, Chang CL, Yuan KS, Wu ATH, Shan YS, Wu SY.

Mar Drugs. 2018 Oct 19;16(10). pii: E392. doi: 10.3390/md16100392.

11.

Multidisciplinary team intervention associated with improved survival for patients with colorectal adenocarcinoma with liver or lung metastasis.

Chen CH, Hsieh MC, Lao WT, Lin EK, Lu YJ, Wu SY.

Am J Cancer Res. 2018 Sep 1;8(9):1887-1898. eCollection 2018.

12.

Treatment outcomes for unresectable intrahepatic cholangiocarcinoma: Nationwide, population-based, cohort study based on propensity score matching with the Mahalanobis metric.

Chang WW, Hsiao PK, Qin L, Chang CL, Chow JM, Wu SY.

Radiother Oncol. 2018 Nov;129(2):284-292. doi: 10.1016/j.radonc.2018.09.010. Epub 2018 Sep 29.

PMID:
30279046
13.

Destruxin B Suppresses Drug-Resistant Colon Tumorigenesis and Stemness Is Associated with the Upregulation of miR-214 and Downregulation of mTOR/β-Catenin Pathway.

Wu SY, Huang YJ, Tzeng YM, Huang CF, Hsiao M, Wu ATH, Huang TH.

Cancers (Basel). 2018 Sep 25;10(10). pii: E353. doi: 10.3390/cancers10100353.

14.

Combination of recurrent oral aphthae and dry eye syndrome may constitute an independent risk factor for oral cavity cancer in elderly women.

Qin L, Kao YW, Lin YL, Peng BY, Deng WP, Chen TM, Lin KC, Yuan KS, Wu AT, Shia BC, Wu SY.

Cancer Manag Res. 2018 Sep 5;10:3273-3281. doi: 10.2147/CMAR.S168477. eCollection 2018.

15.

Letter: cohort study examining the association between proton pump inhibitors therapy and risk of hepatocellular carcinoma in Taiwan-authors' reply.

Shao YJ, Wu SY.

Aliment Pharmacol Ther. 2018 Sep;48(6):690-691. doi: 10.1111/apt.14935. No abstract available.

PMID:
30132942
16.

Intensity-modulated radiotherapy with systemic chemotherapy improves survival in patients with nonmetastatic unresectable pancreatic adenocarcinoma: A propensity score-matched, nationwide, population-based cohort study.

Lin YK, Hsieh MC, Chang CL, Chow JM, Yuan KS, Wu ATH, Wu SY.

Radiother Oncol. 2018 Nov;129(2):326-332. doi: 10.1016/j.radonc.2018.07.012. Epub 2018 Aug 3.

PMID:
30082144
17.

Nano-Diamino-Tetrac (NDAT) Enhances Resveratrol-Induced Antiproliferation by Action on the RRM2 Pathway in Colorectal Cancers.

Nana AW, Wu SY, Yang YS, Chin YT, Cheng TM, Ho Y, Li WS, Liao YM, Chen YR, Shih YJ, Liu YR, Pedersen J, Incerpi S, Hercbergs A, Liu LF, Whang-Peng J, Davis PJ, Lin HY.

Horm Cancer. 2018 Oct;9(5):349-360. doi: 10.1007/s12672-018-0334-9. Epub 2018 Jul 20.

PMID:
30027502
18.

Recurrent aphthous stomatitis may be a precursor or risk factor for specific cancers: A case-control frequency-matched study.

Qin L, Kao YW, Lin YL, Peng BY, Deng WP, Chen TM, Lin KC, Yuan KS, Wu ATH, Shia BC, Wu SY.

Cancer Med. 2018 Aug;7(8):4104-4114. doi: 10.1002/cam4.1685. Epub 2018 Jul 15.

19.

Outcomes of adjuvant treatments for resectable intrahepatic cholangiocarcinoma: Chemotherapy alone, sequential chemoradiotherapy, or concurrent chemoradiotherapy.

Lin YK, Hsieh MC, Wang WW, Lin YC, Chang WW, Chang CL, Cheng YF, Wu SY.

Radiother Oncol. 2018 Sep;128(3):575-583. doi: 10.1016/j.radonc.2018.05.011. Epub 2018 May 22.

PMID:
29801723
20.

Efficacy of thoracic radiotherapy in patients with stage IIIB-IV epidermal growth factor receptor-mutant lung adenocarcinomas who received and responded to tyrosine kinase inhibitor treatment.

Yen YC, Hsu HL, Chang JH, Lin WC, Chang YC, Chang CL, Chow JM, Yuan KS, Wu ATH, Wu SY.

Radiother Oncol. 2018 Oct;129(1):52-60. doi: 10.1016/j.radonc.2018.03.007. Epub 2018 Apr 24.

PMID:
29703499

Supplemental Content

Loading ...
Support Center